Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use, and Region

Description

List of Tables

The global diabetes devices market size is expected to reach USD 67.39 billion by 2034, according to a new study by Polaris Market Research. The report "Diabetes Devices Market Size, Share, Trends, Industry Analysis Report: By Type, Distribution Channel, End Use (Hospitals, Diagnostic Centers, and Homecare), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetes devices help people suffering from diabetes monitor and maintain blood sugar levels, prevent severe complications, and generally improve the quality of life. This proactive approach enhances disease management, improves patient outcomes, and underscores the significant role these devices play in advancing patient care. The diabetes devices market demand is driven by the effectiveness of diabetes devices in reducing hospitalizations and mortality rates.

The incorporation of advanced technologies such as artificial intelligence (AI) and machine learning (ML) in diabetes devices majorly contributes to the growing diabetes devices market revenue. AI and ML help identify underlying risk factors, predict risk complications, and suggest interventions to prevent diabetes-related conditions, such as diabetic retinopathy and nephropathy. These technologies also play a crucial role in improving lifestyle management, fostering positive clinical decisions, and increasing patient engagement. For instance, a study published in the National Library of Medicine in August 2024 highlights how AI and machine learning are being increasingly utilized in diabetes management, significantly improving predictive accuracy, personalized treatment strategies, overall patient outcomes, and healthcare efficiency.

Diabetes device manufacturers are expanding their presence into emerging markets due to factors such as a large elderly population, affordable healthcare, cost-effective labor, and less stringent regulations. Market participants are also capitalizing on technological advancements, including advanced insulin pumps and pens, to cater to the rising demand. For instance, in June 2022, Abbott launched a new continuous glucose and ketone monitoring system, further strengthening its position in the market.

Key Highlights of Diabetes Devices Market Report

Based on type, the insulin delivery devices segment dominated the diabetes devices market share in 2024. The segment's robust growth is attributed to significant technological advancements, such as insulin patches, pumps, and automated insulin delivery (AID) systems.

Based on distribution channel, the hospital pharmacies segment led the market with a revenue share of 56.33% in 2024. This is due to the high volume of patients and the availability of new innovative products in hospital pharmacies.

North America dominated the diabetes devices market with a revenue share of 41.80% in 2024. Various factors such as an rising aging population, increasing incidence of diabetes due to lifestyle changes, and growing prevalence of obesity contribute to the regional market growth.

The Asia Pacific diabetes devices market is expected to register a significant CAGR of 7.45% during the forecast period. The market growth in the region is driven by the presence of leading players and a rising incidence of diabetes. Additionally, advancements in blood glucose monitoring technology are expected to propel market expansion in the region during the forecast period.

A few of the key players in the market are Abbott Diabetes Care; B Braun Melsungen AG; Biocorp; DexCom, Inc.; Johnson & Johnson; GlucoModicum; LifeScan Inc.; Medtronic PLC; Molex; Novo Nordisk; Phillips-Medisize; Roche Diabetes Care; Senseonics, Inc.; and Tandem Diabetes Care, Inc.

Polaris Market Research has segmented the diabetes devices market report on the basis of type, distribution channel, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

BGM Devices
Self-Monitoring Devices
§ Blood Glucose Meters
§ Testing Strips
§ Lancets
Continuous Glucose Monitoring Devices
§ Sensors
§ Transmitters
§ Receiver
Insulin Delivery Devices
Pumps
Pens
Syringes
Jet Injectors

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals
Diagnostic Centers
Homecare

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of the Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1326

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diabetes Devices Market Insights

4.1. Diabetes Devices Market - Market Snapshot
4.2. Diabetes Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Diabetes Prevalence in Developing Economies
  - 4.2.1.2. Technological Advancements in Diabetes Devices
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
4.4. PESTEL Analysis
4.5. Diabetes Devices Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Diabetes Devices Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
5.3. BGM Devices
- 5.3.1. Global Diabetes Devices Market, by BGM Devices, by Region, 2020-2034 (USD Billion)
- 5.3.2. Self-Monitoring Devices
  - 5.3.2.1. Global Diabetes Devices Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
  - 5.3.2.2. Blood Glucose Meters
  - 5.3.2.2.1. Global Diabetes Devices Market, by Blood Glucose Meters, by Region, 2020-2034 (USD Billion)
  - 5.3.2.3. Testing Strips
  - 5.3.2.3.1. Global Diabetes Devices Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
  - 5.3.2.4. Lancets
  - 5.3.2.4.1. Global Diabetes Devices Market, by Lancets, by Region, 2020-2034 (USD Billion)
- 5.3.3. Continuous Glucose Monitoring Devices
  - 5.3.3.1. Global Diabetes Devices Market, by Continuous Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
  - 5.3.3.2. Sensors
  - 5.3.3.2.1. Global Diabetes Devices Market, by Sensors, by Region, 2020-2034 (USD Billion)
  - 5.3.3.3. Transmitters
  - 5.3.3.3.1. Global Diabetes Devices Market, by Transmitters, by Region, 2020-2034 (USD Billion)
  - 5.3.3.4. Receiver
  - 5.3.3.4.1. Global Diabetes Devices Market, by Receiver, by Region, 2020-2034 (USD Billion)
5.4. Insulin Delivery Devices
- 5.4.1. Global Diabetes Devices Market, by Insulin Delivery Devices, by Region, 2020-2034 (USD Billion)
- 5.4.2. Pumps
  - 5.4.2.1. Global Diabetes Devices Market, by Pumps, by Region, 2020-2034 (USD Billion)
- 5.4.3. Pens
  - 5.4.3.1. Global Diabetes Devices Market, by Pens, by Region, 2020-2034 (USD Billion)
- 5.4.4. Syringes
  - 5.4.4.1. Global Diabetes Devices Market, by Syringes, by Region, 2020-2034 (USD Billion)
- 5.4.5. Jet Injectors
  - 5.4.5.1. Global Diabetes Devices Market, by Jet Injectors, by Region, 2020-2034 (USD Billion)

6. Global Diabetes Devices Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
6.3. Hospital Pharmacies
- 6.3.1. Global Diabetes Devices Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
6.4. Retail Pharmacies
- 6.4.1. Global Diabetes Devices Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
6.5. Diabetes Clinics/Centers
- 6.5.1. Global Diabetes Devices Market, by Diabetes Clinics/Centers, by Region, 2020-2034 (USD Billion)
6.6. Online Pharmacies
- 6.6.1. Global Diabetes Devices Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Diabetes Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Diabetes Devices Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Diabetes Devices Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Diagnostic Centers
- 7.4.1. Global Diabetes Devices Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
7.5. Homecare
- 7.5.1. Global Diabetes Devices Market, by Homecare, by Region, 2020-2034 (USD Billion)

8. Global Diabetes Devices Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Diabetes Devices Market Assessment, by Geography, 2020-2034 (USD Billion)
8.3. Diabetes Devices Market - North America
- 8.3.1. North America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.3. North America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.3.4. Diabetes Devices Market - US
  - 8.3.4.1. US: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. US: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.4.3. US: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.3.5. Diabetes Devices Market - Canada
  - 8.3.5.1. Canada: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.4. Diabetes Devices Market - Europe
- 8.4.1. Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.3. Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.4. Diabetes Devices Market - UK
  - 8.4.4.1. UK: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.5. Diabetes Devices Market - France
  - 8.4.5.1. France: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.6. Diabetes Devices Market - Germany
  - 8.4.6.1. Germany: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.7. Diabetes Devices Market - Italy
  - 8.4.7.1. Italy: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.8. Diabetes Devices Market - Spain
  - 8.4.8.1. Spain: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.9. Diabetes Devices Market - Netherlands
  - 8.4.9.1. Netherlands: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.10. Diabetes Devices Market - Russia
  - 8.4.10.1. Russia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.4.11. Diabetes Devices Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.5. Diabetes Devices Market - Asia Pacific
- 8.5.1. Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.4. Diabetes Devices Market - China
  - 8.5.4.1. China: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.5. Diabetes Devices Market - India
  - 8.5.5.1. India: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.6. Diabetes Devices Market - Malaysia
  - 8.5.6.1. Malaysia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.7. Diabetes Devices Market - Japan
  - 8.5.7.1. Japan: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.8. Diabetes Devices Market - Indonesia
  - 8.5.8.1. Indonesia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.9. Diabetes Devices Market - South Korea
  - 8.5.9.1. South Korea: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.10. Diabetes Devices Market - Australia
  - 8.5.10.1. Australia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.5.11. Diabetes Devices Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.6. Diabetes Devices Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.4. Diabetes Devices Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.5. Diabetes Devices Market - UAE
  - 8.6.5.1. UAE: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.6. Diabetes Devices Market - Israel
  - 8.6.6.1. Israel: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.7. Diabetes Devices Market - South Africa
  - 8.6.7.1. South Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.6.8. Diabetes Devices Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
8.7. Diabetes Devices Market - Latin America
- 8.7.1. Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.4. Diabetes Devices Market - Mexico
  - 8.7.4.1. Mexico: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.5. Diabetes Devices Market - Brazil
  - 8.7.5.1. Brazil: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.6. Diabetes Devices Market - Argentina
  - 8.7.6.1. Argentina: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)
- 8.7.7. Diabetes Devices Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Diabetes Devices Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Diabetes Devices Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Diabetes Devices Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Diabetes Care
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. B Braun Melsungen AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Biocorp
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. DexCom, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Johnson & Johnson
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. GlucoModicum
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. LifeScan Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Medtronic PLC
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Molex
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novo Nordisk
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Phillips-Medisize
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Roche Diabetes Care
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Senseonics, Inc.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Tandem Diabetes Care, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development